Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.22 USD -0.85% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Cash from Operating Activities Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Operating Activities
-$202.6m
CAGR 3-Years
-113%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Operating Activities
-$160.3m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Cash from Operating Activities
-ÂŁ117.6m
CAGR 3-Years
-62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Operating Activities
-$145.6m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Operating Activities
ÂŁ2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Operating Activities
ÂŁ29.8m
CAGR 3-Years
-24%
CAGR 5-Years
-2%
CAGR 10-Years
-1%

See Also

What is Bicycle Therapeutics PLC's Cash from Operating Activities?
Cash from Operating Activities
-202.6m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Cash from Operating Activities amounts to -202.6m USD.

What is Bicycle Therapeutics PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-44%

Over the last year, the Cash from Operating Activities growth was -364%. The average annual Cash from Operating Activities growth rates for Bicycle Therapeutics PLC have been -113% over the past three years , -44% over the past five years .

Back to Top